By Charles Toutant | August 16, 2018
"If counsel is now 'scared off' by the prospect of paying for trial, counsel should not have undertaken the representation of plaintiff in the first instance," U.S. Magistrate Judge Joel Schneider said.
By Amanda Bronstad | August 15, 2018
Opioid manufacturers and one distributor say the complaint against them lacks specifics to back up deceptive trade practices and public nuisance claims. But the amicus briefs said none of that mattered because a state has a “unique role” in the opioid crisis.
The Legal Intelligencer | News
By Max Mitchell | August 13, 2018
The ruling allows Pfizer to proceed with its antitrust lawsuit against J&J on allegations that rebate programs J&J entered into with insurers and hospitals were designed to curb competition.
New Jersey Law Journal | Analysis
By Stephen M. Orlofsky and Ethan M. Simon | August 10, 2018
As of last month, most states had adopted Daubert for purposes of their Rule 702 analogues. New Jersey was one of the few exceptions, until now.
By Amanda Bronstad | August 3, 2018
The lawsuits, filed in Pennsylvania, New Jersey, New York, Wisconsin and Massachusetts, allege that Merck failed to warn that the virus in the vaccine caused shingles, brain damage and death, among other things.
By Michael Booth | August 1, 2018
In the ruling, the court adopted the standard set by the U.S. Supreme Court's 1993 decision, "Daubert v. Merrell Dow Pharmaceuticals," which sets a high standard for the use of experts in products liability cases—more stringent than New Jersey's Rule of Evidence 702.
The Legal Intelligencer | News
By Max Mitchell | July 25, 2018
Plaintiffs in the pelvic mesh litigation have accused a Johnson & Johnson subsidiary of judge-shopping after the company asked a Philadelphia judge to recuse from an upcoming trial and also sought to have its appeal of a $13 million verdict assigned to a different appellate panel.
By Amanda Bronstad | July 3, 2018
The Missouri Court of Appeals decision on June 29 is the third ruling to reverse a jury award against Johnson & Johnson over its baby powder, which thousands of lawsuits have alleged caused women to get ovarian cancer.
By Kristen Rasmussen | June 20, 2018
Jonathan Biller, Celgene's senior vice president for tax and treasury and the Summit, New Jersey-based company's treasurer since 2011, will step in as the top lawyer on July 3.
By Charles Toutant | May 31, 2018
A Trenton federal judge has dismissed a False Claims Act suit against Sanofi and Bristol-Myers Squibb over anti-blood clot drug Plavix, citing a change in the composition of the partnership that filed the suit.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...